Notably, anakinra treatment prevented breast cancer progression with a substantial decrease in the proportion of IL-13 producing tumor-infiltrating CD4+ T cells and a concomitant increase of IFN-γ producing CD4+ T cells in a humanized mouse model30. The gene discussed is IL13; the disease is breast carcinoma.